Home » Topics » BioWorld Science

BioWorld Science
RSS

Aronex extends clinical trials with Nyotran

May 20, 1997

Phase I/II results for promising compound from BioTransplant and MedImmune

May 20, 1997

RPR's Azmacort now available in Brazil

May 20, 1997

HemaSure stops development of SteriPath

May 20, 1997

Positive phase II/III results for Cortecs' Macritonin

May 20, 1997

Ribi ImmunoChem offers licenses for cardioprotectant

May 19, 1997

Ribi theraccine available for licensing outside Canada

May 19, 1997

Krenitsky seeks partners for NGF modulators

May 19, 1997

MPL vaccine adjuvant offered for licensing by Ribi

May 19, 1997

Krenitsky seeks partners to develop MAO-A inhibitors

May 19, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 7, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...